Switzerland
# |
Name |
Interest Coverage Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
352.53
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
2 |
101.11
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
3 |
99.06
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
4 |
21.38
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
5 |
17.25
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
6 |
17.19
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
7 |
11.67
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
8 |
9.80
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
9 |
1.93
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
10 |
1.64
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
11 |
-2.92
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
12 |
-3.24
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
13 |
-9.36
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
14 |
-10.41
|
Dec. 31, 2023 | USD 2.41 | 0.50% |
|
Switzerland |
|
15 |
-70.76
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
16 |
-81.34
|
Dec. 31, 2023 | USD 2.03 | -1.93% |
|
Switzerland |
|
17 |
-307.09
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
18 |
-487.56
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
19 |
-1,263.98
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
The Biotechnology company in Switzerland with the highest Interest Coverage Ratio is Bachem Holding AG (Swiss Stock Exchange: BANB.SW) at 352.53.
The Biotechnology company in Switzerland with the lowest Interest Coverage Ratio is Molecular Partners AG (Swiss Stock Exchange: MOLN.SW) at -1,263.98.
The top 10 Biotechnology companies in Switzerland by Interest Coverage Ratio are Bachem Holding AG, Tecan Group AG, Dottikon Es Holding AG, Metall Zug AG, Ypsomed Holding AG, Siegfried Holding AG, Novartis AG, Lonza Group AG, Basilea Pharmaceutica AG and Sandoz Group AG.
The bottom 10 Biotechnology companies in Switzerland by Interest Coverage Ratio are Molecular Partners AG, Addex Therapeutics Ltd, AC Immune SA, NLS Pharmaceutics AG, Kuros Biosciences AG, Meyer Burger Technology AG, PolyPeptide Group AG, ADC Therapeutics SA, DSM-Firmenich AG and Sandoz Group AG.